Precision Optics (POCI) Registration Filing summary
Event summary combining transcript, slides, and related documents.
Registration Filing summary
16 Dec, 2025Company overview and business model
Developer and manufacturer of advanced optical instruments since 1982, focusing on proprietary medical instrumentation, custom design, and manufacturing for minimally invasive surgery and other applications.
Acquired Ross Optical Industries in 2019, expanding into custom optical components for military, defense, medical, and industrial uses.
Acquired Lighthouse Imaging in 2021, adding expertise in advanced optical imaging systems and chip-on-tip visualization for medical devices.
Revenue streams include engineering services, sale of optical components, and manufacturing of assemblies, with a shift toward higher component sales in 2023.
Technology developed for medical devices is also applicable to defense and aerospace sectors.
Financial performance and metrics
Operating losses of $638,548 in 2023 and $1,513,890 in 2022; accumulated deficit of $48,239,007 as of June 30, 2023.
Working capital increased to $4,599,536 in 2023 from $1,918,575 in 2022.
Raised $2.52 million in gross proceeds from a private placement in June 2023 and increased bank credit facilities.
As of June 4, 2024, market value of outstanding common stock held by non-affiliates was approximately $27.6 million.
Use of proceeds and capital allocation
Net proceeds from securities sales will be used for general corporate purposes, including working capital and acquisitions.
Any specific use of proceeds for an offering will be detailed in the relevant prospectus supplement.
Latest events from Precision Optics
- Record revenue growth offset by margin compression and liquidity risks.POCI
Q2 202617 Feb 2026 - Shareholders will vote on director elections, executive pay, and auditor ratification at the 2025 meeting.POCI
Proxy Filing3 Feb 2026 - Votes will be cast on director elections, executive pay, and auditor ratification at the 2026 meeting.POCI
Proxy Filing2 Feb 2026 - Annual meeting to elect directors, approve executive pay, and ratify auditor, with strong governance.POCI
Proxy Filing2 Feb 2026 - Record engineering revenue and new orders support double-digit growth expectations for FY2025.POCI
Q4 202420 Jan 2026 - Strong product pipeline and new production ramp-ups set the stage for record growth in 2025.POCI
Lytham Partners Fall 2024 Investor Conference19 Jan 2026 - Net loss widened on lower revenue and margin, but growth is expected as new programs scale.POCI
Q1 202514 Jan 2026 - Single-use endoscopes and the Unity platform are fueling rapid growth and production expansion.POCI
Lytham Partners 2025 Industrials & Basic Materials Investor Summit26 Dec 2025 - Production revenue surged 42% sequentially, with Unity Imaging Platform launch fueling optimism.POCI
Q2 202524 Dec 2025